Biology Reference
In-Depth Information
Amerasinghe, F.P., Amerasinghe, P.H., Peiris, J.S., Wirtz, R.A., 1991b. Anopheline ecology
and malaria infection during the irrigation development of an area of the Mahaweli
Project, Sri Lanka. Am. J. Trop. Med. Hyg. 45, 226-235.
Amerasinghe, F.P., Indrajith, N.G., 1994. Postirrigation breeding patterns of surface water
mosquitoes in the Mahaweli Project, Sri Lanka, and comparisons with preceding devel-
opmental phases. J. Med. Entomol. 31, 516-523.
Anonymous, 2009. Kenya Malaria Monitoring and Evaluation Plan 2009-2017.
Anstey, N.M., Russell, B.,Yeo, T.W., Price, R.N., 2009. The pathophysiology of vivax malaria.
Trends Parasitol. 25, 220-227.
Antonio-Nkondjio, C., Simard, F., Awono-Ambene, P., Ngassam, P., Toto, J.C., Tchuinkam, T.,
Fontenille, D., 2005. Malaria vectors and urbanization in the equatorial forest region of
south Cameroon. Trans. R. Soc. Trop. Med. Hyg. 99, 347-354.
Arevalo-Herrera, M., Chitnis, C., Herrera, S., 2010. Current status of
Plasmodium vivax
vac-
cine. Hum. Vaccin. 6, 124-132.
Attenborough, R.D., Burkot, T.R., Gardner, D.S., 1997. Altitude and the risk of bites from
mosquitoes infected with malaria and filariasis among the Mianmin people of Papua
New Guinea. Trans. R. Soc. Trop. Med. Hyg. 91, 8-10.
Awab, G.R., Pukrittayakamee, S., Imwong, M., Dondorp, A.M., Woodrow, C.J., Lee, S.J., Day,
N.P., Singhasivanon, P., White, N.J., Kaker, F., 2010. Dihydroartemisinin-piperaquine
versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-
inferiority, trial. Malar. J. 9, 105.
Baimai, V., Harbach, R.E., Sukowati, S., 1988. Cytogenetic evidence for two species within
the current concept of the malaria vector
Anopheles leucosphyrus
in Southeast Asia. J. Am.
Mosq. Control Assoc. 4, 44-50.
Baird, J.K., 2004. Chloroquine resistance in
Plasmodium vivax
. Antimicrob. Agents Che-
mother. 48, 4075-4083.
Baird, J.K., 2007. Neglect of
Plasmodium vivax
malaria. Trends Parasitol. 23, 533-539.
Baird, J.K., 2009. Resistance to therapies for infection by
Plasmodium vivax
. Clin. Microbiol.
Rev. 22, 508-534.
Baird, J.K., 2010. Eliminating malaria - all of them. Lancet 376, 1883-1885.
Baird, J.K., Hoffman, S.L., 2004. Primaquine therapy for malaria. Clin. Infect. Dis. 39,
1336-1345.
Baird, J.K., Rieckmann, K.H., 2003. Can primaquine therapy for vivax malaria be improved?.
Trends Parasitol. 19, 115-120.
Baird, J.K., Schwartz, E., Hoffman, S.L., 2007. Prevention and treatment of vivax malaria. Curr.
Infect. Dis. Rep. 9, 39-46.
Baker, E.Z., Beier, J.C., Meek, S.R., Wirtz, R.A., 1987. Detection and quantification of
Plasmodium falciparum
and
P. vivax
infections in Thai-Kampuchean Anopheles (Diptera:
Culicidae) by enzyme-linked immunosorbent assay. J. Med. Entomol. 24, 536-541.
Balk, D.L., Deichmann, U., Yetman, G., Pozzi, F., Hay, S.I., Nelson, A., 2006. Determin-
ing global population distribution: methods, applications and data. Adv. Parasitol.
62, 119-156.
Barcus, M.J., Laihad, F., Sururi, M., Sismadi, P., Marwoto, H., Bangs, M.J., Baird, J.K.,
2002. Epidemic malaria in the Menoreh Hills of Central Java. Am. J. Trop. Med. Hyg.
66, 287-292.
Barik, T.K., Sahu, B., Swain, V., 2009. A review on
Anopheles culicifacies
: from bionomics to
control with special reference to Indian subcontinent. Acta Trop. 109, 87-97.
Barnwell, J.W., Nichols, M.E., Rubinstein, P., 1989.
In vitro
evaluation of the role of
the Duffy blood group in erythrocyte invasion by
Plasmodium vivax
. J. Exp. Med.
169, 1795-1802.
Basseri, H.R., Doosti, S., Akbarzadeh, K., Nategpour, M., Whitten, M.M., Ladoni, H., 2008.
Competency of
Anopheles stephensi mysorensis
strain for
Plasmodium vivax
and the role of
inhibitory carbohydrates to block its sporogonic cycle. Malar. J. 7, 131.
